Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, John K. Lee|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0